Evidence map›Paper›PMID 21396623›Full record

ArticleAmerican journal of ophthalmology2011

Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Efe Sezgin, Mark L van Natta, Alka Ahuja, Alice Lyon, Sunil Srivastava, Jennifer L Troyer, Stephen J O'Brien, Douglas A Jabs, Studies of the Ocular Complications of AIDS Research Group

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in American journal of ophthalmology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00000168 (Studies of Ocular Complications of AIDS), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00000168 completednot on this map

Studies of Ocular Complications of AIDS (SOCA)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan1998 to 2013Enrolled2,392ConditionsHIV Infections, Acquired Immunodeficiency Syndrome, Cytomegalovirus Retinitis
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Observational
  7. Review
  8. Cytomegalovirus retinitis in the post-cART era.Current ophthalmology reports · 2018
    Article
  9. Article
  10. Article
  11. Evaluation of hepatitis C virus as a risk factor for HIV-associated neuroretinal disorder.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2013
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Efe SezginLaboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702, USA. efe.sezgin@nih.gov
Mark L van Natta
Alka Ahuja
Alice Lyon
Sunil Srivastava
Jennifer L Troyer
Stephen J O'Brien
Douglas A Jabs
Studies of the Ocular Complications of AIDS Research Group
Johns Hopkins University · USFrederick National Laboratory for Cancer Research · USEmory University · USNorthwestern University · USScience Applications International Corporation (United States) · US

Funding

Studies of Ocular Complications of AIDS - Coordinating CenterU10EY008057 · NEI · JOHNS HOPKINS UNIVERSITY · PI VAN NATTA, MARK L · 1988 to 2012
$78.0M
ZOPOLRESTAT IN NORMOTENSIVE, TYPE 1 DIA WITH INCIPIENT NEPHROPATHYM01RR000043 · NCRR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZAIA, JOHN A · 1985 to 2010
$76.4M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR024996 · NCRR · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2007 to 2011
$49.6M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Zonisamide in Patients with Neuropathic Pain Associated with Diabetic NeuropathyM01RR000046 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOY, MELANIE S · 1985 to 2008
$38.5M
ZOPOLRESTAT IN SUBJECTS W/ PERIPHERAL SYMMETRICAL DIABETIC POLYNEUROPATHYM01RR000096 · NCRR · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI NOVIK, YELENA · 1985 to 2008
$34.8M
ZENARESTAT IN DIABETIC NEUROPATHYM01RR005096 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI FONSECA, VIVIAN A · 1990 to 2006
$17.4M
WOMEN'S HEALTH AGENDAU01AI025868 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ERON, JOSEPH J. · 1987 to 2006
$14.9M
WOMEN'S HEALTH AGENDAU01AI027670 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BENSON, CONSTANCE ANN · 1988 to 2006
$13.7M
WOMEN'S HEALTH AGENDAU01AI032783 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI TEBAS, PABLO · 1992 to 2007
$11.9M
WOMEN'S HEALTH AGENDAU01AI027660 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CURRIER, JUDITH S. · 1988 to 2006
$11.8M
WOMEN'S HEALTH AGENDAU01AI027663 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 1988 to 2006
$11.4M
Intramural NIH HHS Z99 CA999999NCI NIH HHS N01 CO012400NCRR NIH HHS 5M01 RR00043NCRR NIH HHS 5M01 RR00046NCRR NIH HHS 5M01 RR00096NCRR NIH HHS 5M01 RR 00350NCRR NIH HHS 5M01 RR00865NCRR NIH HHS 5M01 RR 05096NCRR NIH HHS ULI RR024996NEI NIH HHS U10 EY008057NEI NIH HHS U10 EY008067NEI NIH HHS U10 EY 08052NEI NIH HHS U10 EY 08057NEI NIH HHS U10 EY 08067NIAID NIH HHS U01 AI25868NIAID NIH HHS U01 AI 27660NIAID NIH HHS U01 AI 27663NIAID NIH HHS U01 AI 27670NIAID NIH HHS U01 AI 27674NIAID NIH HHS U01 AI32783
6 · The paper itself

Abstract

purposeTo evaluate the effects of previously reported host genetics factors that influence cytomegalovirus (CMV) retinitis incidence, progression to acquired immune deficiency syndrome (AIDS), and efficacy of highly active antiretroviral therapy (HAART) for mortality, retinitis progression, and retinal detachment in patients with CMV retinitis and AIDS in the era of HAART.

designProspective, multicenter, observational study.

methodsCox proportional hazards model based genetic association tests examined the influence of IL-10R1_S420L, CCR5-Δ32, CCR2-V64I, CCR5 promoter, and SDF-3'A polymorphisms among patients with mortality, retinitis progression, and retinal detachment. Participants were 203 European-American and 117 African-American patients with AIDS and CMV retinitis.

resultsEuropean-American patients with the CCR5 +.P1.+ promoter haplotype showed increased risk for mortality (hazard ratio [HR] = 1.83; 95% confidence interval [CI]: 1.00-3.40; P = .05). Although the same haplotype also trended for increased risk for mortality in African-American patients, the result was not significant (HR = 2.28; 95% CI: 0.93-5.60; P = .07). However, this haplotype was associated with faster retinitis progression in African Americans (HR = 5.22; 95% CI: 1.54-17.71; P = .007). Increased risk of retinitis progression was also evident for African-American patients with the SDF1-3'A variant (HR = 3.89; 95% CI: 1.42-10.60; P = .008). In addition, the SDF1-3'A variant increased the retinal detachment risk in this patient group (HR = 3.05; 95% CI: 1.01-9.16; P = .05).

conclusionBesides overall immune health, host genetic factors influence mortality, retinitis progression, and retinal detachment in patients with AIDS and CMV retinitis that are receiving HAART.

Indexed as

Genetic Predisposition to DiseaseAdultAIDS-Related Opportunistic InfectionsAntiretroviral Therapy, Highly ActiveBlack or African AmericanBlack PeopleCD4 Lymphocyte CountChemokine CXCL12Cytomegalovirus RetinitisDisease ProgressionFemaleGenotypeHIV-1HumansInterleukin-10 Receptor alpha SubunitMaleCCR2 protein, humanChemokine CXCL12Interleukin-10 Receptor alpha SubunitReceptors, CCR2Receptors, CCR5

Identifiers

PMID21396623
PMCPMC3103625
OpenAlexW2007411070

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.